ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 65 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $118,000 | +7.3% | 12,831 | -10.0% | 0.00% | – |
| Q4 2016 | $110,000 | -27.2% | 14,263 | +8.1% | 0.00% | -100.0% |
| Q3 2016 | $151,000 | -63.1% | 13,193 | -60.3% | 0.00% | -50.0% |
| Q2 2016 | $409,000 | +20.6% | 33,202 | -1.1% | 0.00% | +100.0% |
| Q1 2016 | $339,000 | -56.6% | 33,569 | -3.2% | 0.00% | -66.7% |
| Q4 2015 | $782,000 | +36.0% | 34,684 | +0.0% | 0.00% | 0.0% |
| Q3 2015 | $575,000 | +133.7% | 34,678 | +217.2% | 0.00% | +200.0% |
| Q2 2015 | $246,000 | +2.5% | 10,933 | +17.6% | 0.00% | 0.0% |
| Q1 2015 | $240,000 | +14.8% | 9,293 | -3.1% | 0.00% | 0.0% |
| Q4 2014 | $209,000 | +13.6% | 9,590 | -1.4% | 0.00% | 0.0% |
| Q3 2014 | $184,000 | -17.9% | 9,724 | +1.2% | 0.00% | 0.0% |
| Q2 2014 | $224,000 | +83.6% | 9,611 | +165.5% | 0.00% | 0.0% |
| Q1 2014 | $122,000 | +14.0% | 3,620 | 0.0% | 0.00% | – |
| Q4 2013 | $107,000 | -13.0% | 3,620 | -55.0% | 0.00% | -100.0% |
| Q3 2013 | $123,000 | – | 8,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,400,289 | $19,889,000 | 2.53% |
| ADAMS STREET PARTNERS LLC | 1,473,061 | $6,658,000 | 1.70% |
| Iguana Healthcare Management, LLC | 700,000 | $3,164,000 | 0.87% |
| Perceptive Advisors | 2,076,578 | $9,386,000 | 0.18% |
| Birchview Capital, LP | 28,689 | $130,000 | 0.07% |
| Cannell & Co. | 303,971 | $1,374,000 | 0.05% |
| ELEMENT CAPITAL MANAGEMENT LLC | 25,249 | $114,000 | 0.05% |
| NJ State Employees Deferred Compensation Plan | 38,000 | $172,000 | 0.03% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 313,775 | $1,418,000 | 0.03% |
| Candriam S.C.A. | 370,000 | $1,672,000 | 0.03% |